Velan Capital Investment Management LP Quant / Systematic

CIK: 0001848809 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $106,939 (100.0% shares, 0.0% debt)

Holdings (18)

JSPR JASPER THERAPEUTICS INC 25.2%
Value ($000) $26,970 Shares 1,433,828 Est. Cost $17.76 Unrealized +12.1%
PRAX PRAXIS PRECISION MEDICINES I 18.9%
Value ($000) $20,177 Shares 350,666 Est. Cost $18.39 Unrealized +193.7%
XBI SPDR SER TR 13.9%
Value ($000) $14,820 Shares 150,000 Est. Cost Unrealized
HRTX HERON THERAPEUTICS INC 13.0%
Value ($000) $13,904 Shares 6,986,744 Est. Cost $2.38 Unrealized +0.5%
TOURMALINE BIO INC 8.0%
Value ($000) $8,515 Shares 331,190 Est. Cost $26.16 Unrealized
RZLT REZOLUTE INC 3.6%
Value ($000) $3,880 Shares 800,000 Est. Cost $2.43 Unrealized +89.0%
LQDA LIQUIDIA CORPORATION 2.8%
Value ($000) $3,000 Shares 300,000 Est. Cost $10.92 Unrealized 0.0%
CNTX CONTEXT THERAPEUTICS INC 2.4%
Value ($000) $2,529 Shares 1,290,323 Est. Cost $1.72 Unrealized +28.7%
NSPR INSPIREMD INC 2.3%
Value ($000) $2,423 Shares 904,029 Est. Cost $1.59 Unrealized +71.4%
SCPHARMACEUTICALS INC 2.2%
Value ($000) $2,361 Shares 517,668 Est. Cost $4.56 Unrealized
TELA TELA BIO INC 1.8%
Value ($000) $1,891 Shares 747,410 Est. Cost $7.03 Unrealized -49.4%
OPTINOSE INC 1.3%
Value ($000) $1,438 Shares 2,146,608 Est. Cost $2.21 Unrealized
ZVRA ZEVRA THERAPEUTICS INC 1.3%
Value ($000) $1,388 Shares 200,000 Est. Cost $6.78 Unrealized 0.0%
TARA PROTARA THERAPEUTICS INC 1.0%
Value ($000) $1,050 Shares 574,000 Est. Cost $2.78 Unrealized -26.1%
CRBP CORBUS PHARMACEUTICALS HLDGS 1.0%
Value ($000) $1,032 Shares 50,000 Est. Cost $51.17 Unrealized 0.0%
SKYE SKYE BIOSCIENCE INC 0.8%
Value ($000) $825 Shares 211,071 Est. Cost $11.84 Unrealized -52.6%
KPRX KIORA PHARMACEUTICALS INC 0.4%
Value ($000) $447 Shares 122,223 Est. Cost $4.67 Unrealized -16.4%
TENX TENAX THERAPEUTICS INC 0.3%
Value ($000) $288 Shares 83,333 Est. Cost $3.62 Unrealized 0.0%